STOCK TITAN

Profusa (NASDAQ: NVACW) investor group caps stake at 9.99% ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Profusa, Inc. received an amended Schedule 13G reporting that a group of related investment entities and individuals, led by Ascent Partners Fund LLC and affiliates of Dominion Capital and Masada Group, beneficially own up to 9,590,920 shares of common stock.

This position represents 9.99% of Profusa’s common shares as of December 31, 2025, based on 86,414,296 shares outstanding as of December 23, 2025. The stake includes shares issuable from convertible promissory notes and purchases under a Securities Purchase Agreement (ELOC Agreement), all subject to a contractual 9.99% “Blocker” that prevents the group from exceeding that ownership level.

The reporting persons share voting and dispositive power over 9,590,920 shares and report no sole voting or dispositive power. They certify the holdings were not acquired to change or influence control of Profusa, characterizing the position as a passive investment.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of common stock, par value $0.0001 per share, of the issuer (the "Common Stock") set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount (as defined in this footnote), the shares of Common Stock to be issued upon (a) conversions of convertible promissory notes (the "Convertible Notes"), effective July 11, 2025 and December 29, 2023 respectively, held directly by the reporting person and (b) purchases by the reporting person pursuant to that certain Securities Purchase Agreement, dated as of July 28, 2025, between the issuer and the reporting person (the "ELOC Agreement") whereby, subject to certain conditions, the issuer may, at its option but subject to the Blocker Amount, require the reporting person to purchase Common Stock. The Convertible Notes and ELOC Agreement are all subject to a maximum 9.99% beneficial ownership limitation contained therein (the "Blocker Amount"). In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on January 2, 2026 (the "Definitive Proxy Statement") and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes, and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Note and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 86,414,296 shares of Common Stock outstanding as of December 23, 2025, as reported by the issuer in its Definitive Proxy Statement and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G



Ascent Partners Fund LLC
Signature:/s/ Ascent Partners Fund LLC
Name/Title:Mikhail Gurevich, signatory for Managing Member of Managing Member
Date:02/09/2026
Ascent Partners LLC
Signature:/s/ Ascent Partners LLC
Name/Title:Mikhail Gurevich, signatory for Managing Member
Date:02/09/2026
Dominion Capital LLC
Signature:/s/ Dominion Capital LLC
Name/Title:Mikhail Gurevich, Managing Member of Dominion Capital Holdings LLC, Manager of Dominion Capital GP LLC, Manager of Dominion Capital LLC
Date:02/09/2026
Dominion Capital GP LLC
Signature:/s/ Dominion Capital GP LLC
Name/Title:Mikhail Gurevich, Managing Member of Dominion Capital Holdings LLC, Manager of Dominion Capital GP LLC
Date:02/09/2026
Dominion Capital Holdings LLC
Signature:/s/ Dominion Capital Holdings LLC
Name/Title:Mikhail Gurevich, Managing Member
Date:02/09/2026
Masada Group Holdings LLC
Signature:/s/ Masada Group Holdings LLC
Name/Title:Alon Brenner, Managing Member
Date:02/09/2026
Mikhail Gurevich
Signature:/s/ Mikhail Gurevich
Name/Title:Mikhail Gurevich
Date:02/09/2026
Gennadiy Gurevich
Signature:/s/ Gennadiy Gurevich
Name/Title:Gennadiy Gurevich
Date:02/09/2026
Alon Brenner
Signature:/s/ Alon Brenner
Name/Title:Alon Brenner
Date:02/09/2026

Comments accompanying signature: LIST OF EXHIBITS Exhibit No. 1 - Joint Filing Agreement, dated November 13, 2025 (incorporated by reference to Exhibit 1 to the Schedule 13G/A filed by the Reporting Persons with the SEC on November 13, 2025)

FAQ

What stake in Profusa does the NVACW reporting group disclose?

The reporting group discloses beneficial ownership of up to 9,590,920 shares of Profusa common stock, equal to 9.99% of the class. This figure includes shares already issued plus shares issuable from convertible notes and an equity purchase agreement.

Who are the main investors in the Profusa Schedule 13G/A linked to NVACW?

The filing lists Ascent Partners Fund LLC, Ascent Partners LLC, several Dominion Capital entities, Masada Group Holdings LLC, and individuals Mikhail Gurevich, Gennadiy Gurevich, and Alon Brenner as reporting persons, all jointly reporting the same 9,590,920-share position.

How did the NVACW-related group build its 9.99% Profusa position?

The position includes Profusa common shares issuable upon conversion of convertible promissory notes and purchases under a Securities Purchase Agreement called the ELOC Agreement. These instruments together contribute to the 9,590,920-share beneficial ownership figure.

What is the 9.99% ownership blocker described in the Profusa 13G/A?

Both the convertible notes and the ELOC Agreement contain a 9.99% beneficial ownership limitation, called the Blocker. It prevents the reporting group from converting or purchasing additional shares if doing so would push their ownership above 9.99% of Profusa’s outstanding common stock.

Is the NVACW reporting group seeking control of Profusa, Inc.?

The group certifies the securities were not acquired and are not held to change or influence control of Profusa. Instead, they characterize the holdings as a passive investment, consistent with a Schedule 13G filing rather than a control-oriented Schedule 13D.

What Profusa share count underlies the 9.99% ownership calculation?

The 9.99% ownership figure is based on 86,414,296 Profusa common shares outstanding as of December 23, 2025, as disclosed in Profusa’s definitive proxy statement, plus shares issued from partial note conversions and ELOC purchases, all still capped by the Blocker.
Profusa Inc

OTC:NVACW

NVACW Rankings

NVACW Latest SEC Filings

NVACW Stock Data